GlaxoSmithKline and NeuroSearch to Investigate CNS Diseases
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)
Published: 4 Feb-2004
DOI: 10.3833/pdr.v2004.i44.828 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
GlaxoSmithKline formed a 5 year research and development alliance with NeuroSearch for several research programs for treating CNS diseases such as depression, anxiety and schizophrenia in a deal worth up to €82 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS